tiprankstipranks
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
US Market
RNA
Atrium Therapeutics, Inc.
RESEARCH TOOLSreports

Atrium Therapeutics, Inc. (RNA) Balance Sheet

6 Followers

Atrium Therapeutics, Inc. Balance Sheet

Atrium Therapeutics, Inc.'s total assets for Q4 2025 were $278.35M, a decrease of -86.96% from the previous quarter. RNA total liabilities were $71.07M for the fiscal quarter, a -71.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 278.35M$ 1.56B$ 628.55M$ 638.80M$ 427.58M
Total Liabilities
$ 71.07M$ 138.94M$ 127.79M$ 60.73M$ 46.15M
Total Equity Gross Minority
$ 207.29M$ 1.42B$ 500.76M$ 578.08M$ 381.43M
Other Metrics
Currency in USD

Atrium Therapeutics, Inc. Debt to Assets